Kyntra Bio, Inc. (KYNB)

6.99 -0.11 (-1.55%) USD  |  NASDAQ  |  Sep 18, 16:00
6.99 0.00 (0.00%) After-Hours: 16:18
More

Kyntra Bio EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for KYNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 31, 2026 --
August 14, 2026 --
July 06, 2026 --
May 12, 2026 --
March 17, 2026 --
March 16, 2026 --
March 02, 2026 --
February 24, 2026 --
November 11, 2025 --
October 31, 2025 --
September 24, 2025 --
August 12, 2025 --
August 07, 2025 --
July 14, 2025 --
Date Value
May 13, 2025 --
April 01, 2025 --
March 18, 2025 --
February 20, 2025 --
November 13, 2024 --
August 09, 2024 --
August 07, 2024 --
July 30, 2024 --
June 26, 2024 --
June 03, 2024 --
May 24, 2024 --
May 07, 2024 --
April 03, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Vericel Corp. Upgrade
Capricor Therapeutics, Inc. Upgrade
ARS Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade